What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Guidance on practical actions in your 30s to set up a strong retirement, including saving, debt management, and early investment habits.
16,695 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Nuscale Power stock has drawn attention for a potential 195% upside from some analysts. This article breaks down what...
Meme coins surged with viral fame, but a political push to bar elected officials from launching them could reshape th...
As shipping cycles turn, Safe Bulkers faces a critical earnings season. This guide deconstructs the Q4 2025 call, hig...
A major insider move is lighting up the markets as Fluor dumps million shares of NuScale SMR for $1.35 billion. Here’...
MiMedx (MDXG) 2025 earnings scrutiny goes beyond one quarter. This guide breaks down what to watch in the Q4 call, ho...
As investors await plug power (plug) 2025 Q4 results, this guide breaks down what the earnings call transcript could ...
A deep dive into MiB: Bill Gurley, Benchmark—how a pioneering VC built a team culture, backed Uber and other giants, ...
Prediction market ETFs may grab headlines, but long-term investors should weigh the real costs and risks. This guide ...
A big-name investment fund backed an IoT stock with a $20 million stake last quarter. Since then, the stock has tumbl...
The market recently pulled back from UPS gains, but a dip can signal opportunity for patient investors. This guide la...
Investors are asking if this lucid make investors wealthier. The answer lies in Lucid's disciplined path to scale, ma...